메뉴 건너뛰기




Volumn 94, Issue 4, 2000, Pages 429-431

A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis

Author keywords

Adverse events; Chemotherapy; Clinical trial; Drug combinations; Efficacy; India; Paromomycin; Sodium stibogluconate; Visceral leishmaniasis

Indexed keywords

AMINOGLYCOSIDE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

EID: 0033847913     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(00)90130-5     Document Type: Article
Times cited : (100)

References (14)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.